Registration has now closed!
33rd Annual Meeting 2019
The 33rd Annual Meeting Sponsored by Gentronix will be held from the 19th – 20th June 2019 at Deansgate Hilton, Manchester.
The meeting will start on the evening of the 19th with a keynote from David Kirkland on “Regulatory Assessment of Genotoxicity Data: Past, Present and Future” followed by a drinks reception, sponsored by Instem and Litron Laboratories, and bowl food, an excellent opportunity for networking and catching up with colleagues.
The 20th will have half a day on “Regulatory Genetic Toxicology: Theory” covering new challenges including oligos and medical devices, while the afternoon will be interactive workshops on proof of exposure and when negative is equivocal.
There are travel bursaries available as well as reduced rates for members of EEMGS and affiliated societies.
Accommodation is available at the Hilton at £175 for one night with breakfast using the code AIGG19 on the Hilton website, or alternatively by contacting the reservation manager Jack Naylor (0161 870 1641 or Jack.firstname.lastname@example.org) to make a booking directly by the end of the 31st of May.
For ideas for alternative hotels see the map below.
Wednesday 19th June Evening Session
|18:00-19:00||Registration and Welcome with Canapes|
|19:00-20:00||Regulatory Assessment of Genotoxicity Data: Past, Present and Future||David Kirkland||Kirkland Consulting|
|20:00-23:00||Networking with drinks and bowl food|
Thursday 20th June Morning Session
|09:30-10:00||Coffee, Registration and Welcome|
|10:00-10:30||Genetox testing of medical devices – how different can it be?||Phil Clay||Chorley Consulting|
|10:30-11:00||How low can you go? An analysis of lowest effective dose in the Ames test.||Paul Rawlinson||Gentronix|
|11:00-11:30||Should the full gene tox battery be needed for antisense oligos?||Ann Doherty||AstraZeneca|
|11:30-12:00||Deriving compound-specific acceptable daily intakes/Permissible Daily Exposures for impurities in pharmaceuticals||Liz Martin||AstraZeneca|
|12:00-12:15||Annual General Meeting|
Thursday 20th June Afternoon Session
|13:30-14:20||Genotoxicity assessment of an agrochemical by conservative EU member states and EFSA||Eva Lessmann and Paul Rawlinson||Syngenta and Gentronix|
||Regulatory approaches to using HCD for interpretation of genotoxicity studies||Carol Beevers||Exponent|
|15:00-15:25||MLA data: contradictory data and the trouble with regulators||Damian Bowen||ERM|
|15:25-15:50||Case study with ethopropos||Paul Fowler||FSTox Consulting|
|16:00||Close of Meeting|